Physician profile

Wayne L Bruffett

Orthopaedic Surgery of the Spine · North Little Rock, AR

NPI 1952389280

$3,826.37

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$900.00
Food and Beverage$281.23

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Spine Wave, INC. $2,013.18 2019
Medical Device Business Services, INC. $900.00 2023
Depuy Synthes Sales INC. $483.73 2019-2024 X-Pac, Conduit, Fibergraft Bg Morsels
Medtronic USA, INC. $182.47 2019
Globus Medical, INC. $98.73 2019
Midsouth Orthopedics INC. $56.27 2024
Spinal Elements, INC. $34.49 2021
Horizon Therapeutics Plc $31.53 2021
Si-Bone, INC. $25.97 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Wayne L Bruffett

$3,826.37

in general payments reported 2019-2025

Years
2019-2024
Top company
Spine Wave, INC.

https://glasscript.com/doctor/1016855/wayne-l-bruffett

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.